Tranylcypromine: a promising repurposed drug against Leishmaniases [PDF]
Frontiers in MicrobiologyLeishmaniases remain a major global health challenge due to limited and often toxic therapeutic options. Recent advances in artificial intelligence have enabled the identification of novel antileishmanial candidates through drug repurposing approaches ...
Rafeh Oualha +4 more
doaj +2 more sources
Tranylcypromine upregulates Sestrin 2 expression to ameliorate NLRP3-related noise-induced hearing loss [PDF]
Neural Regeneration ResearchNoise-induced hearing loss is the primary non-genetic factor contributing to auditory dysfunction. However, there are currently no effective pharmacological interventions for patients with noise-induced hearing loss.
Xihang Chen +9 more
doaj +2 more sources
Quercetin and Tranylcypromine Improve Memory, Behavioral Performance, and Cholinergic Function in Male Rats Subjected to Chronic Restraint Stress [PDF]
Brain SciencesBackground/Objectives: Major depressive disorder (MDD) is a debilitating illness, and chronic stress is a contributing factor for depressive symptoms. However, despite intense research, the mechanisms of MDD remain substantially unidentified.
Vitor Bastianello Mostardeiro +14 more
doaj +2 more sources
The Combination of Two Small Molecules Improves Neurological Parameters and Extends the Lifespan of C3H Strain Female Mice [PDF]
Brain and BehaviorObjectives Targeting partial cellular reprogramming pathways through specific small molecule combinations holds promise for lifespan extension in model organisms.
Maria Vedunova +5 more
doaj +2 more sources
LSD1 inhibition by tranylcypromine hydrochloride reduces alkali burn-induced corneal neovascularization and ferroptosis by suppressing HIF-1α pathway [PDF]
Frontiers in PharmacologyBackgroundCorneal neovascularization (CNV) is a sight-threatening condition that necessitates epigenetic control. The role of lysine-specific demethylase 1 (LSD1) in CNV remains unclear, despite its established significance in tumor angiogenesis ...
Qian Deng +8 more
doaj +2 more sources
NLRP3 inflammasome and hearing loss: from mechanisms to therapies [PDF]
Journal of NeuroinflammationThe NLRP3 inflammasome, a key component of the innate immune system, has emerged as a central mediator of inflammation-driven sensorineural hearing loss (SNHL).
Silvia Murillo-Cuesta +4 more
doaj +2 more sources
Tranylcypromine: a red flag for broader reflection [PDF]
Brazilian Journal of PsychiatryLarissa Junkes, Antonio E. Nardi
doaj +2 more sources
Cells, 2022 Mesenchymal stromal cells (MSCs) are commonly known for their immune-suppressive abilities. However, our group provided evidence that it is possible to convert MSCs into potent antigen presenting cells (APCs) using either genetic engineering or ...
Fatemeh Mardani +7 more
doaj +1 more source
Safety of concomitant tranylcypromine treatment during electroconvulsive therapy (ECT) series
European Psychiatry, 2022 Introduction Tranylcypromine (TCP), an irreversible monoamine oxidase inhibitor (MAOI), is recommended for difficult-to-treat depression. Besides the requirement of a low-tyramine diet, there are concerns about the safety of TCP treatment during ...
E. Kavakbasi +3 more
doaj +1 more source
Cells, 2020 Monoamine oxidase (MAO) has been implicated in neuroinflammation, and therapies targeting MAO are of interest for neurodegenerative diseases. The small-molecule drug tranylcypromine, an inhibitor of MAO, is currently used as an antidepressant and in the ...
HyunHee Park +11 more
doaj +1 more source